Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
54.97
+0.96 (1.78%)
At close: Jun 3, 2026, 4:00 PM EDT
54.09
-0.88 (-1.61%)
After-hours: Jun 3, 2026, 7:28 PM EDT
Royalty Pharma Employees
Royalty Pharma had 100 employees as of December 31, 2025. The number of employees increased by 1 or 1.01% compared to the previous year.
Employees
100
Change (1Y)
1
Growth (1Y)
1.01%
Revenue / Employee
$24,405,220
Profits / Employee
$8,262,880
Market Cap
31.65B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 100 | 1 | 1.01% |
| Dec 31, 2024 | 99 | 10 | 11.24% |
| Dec 31, 2023 | 89 | 14 | 18.67% |
| Dec 31, 2022 | 75 | 9 | 13.64% |
| Dec 31, 2021 | 66 | 15 | 29.41% |
| Dec 31, 2020 | 51 | 16 | 45.71% |
| Dec 31, 2019 | 35 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
RPRX News
- 15 days ago - Royalty Pharma Transcript: RBC Capital Markets Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Royalty Pharma Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Royalty Pharma Slides: Corporate presentation - Filings
- 27 days ago - Royalty Pharma to present at upcoming investor conferences - GlobeNewsWire
- 27 days ago - Royalty Pharma price target raised to $64 from $63 at Morgan Stanley - TheFly
- 27 days ago - Royalty Pharma price target raised to $58 from $50 at JPMorgan - TheFly
- 27 days ago - Royalty Pharma price target raised to $66 from $50 at Citi - TheFly
- 4 weeks ago - Royalty Pharma Earnings Call Transcript: Q1 2026 - Transcripts